Telepsychiatry to Enable Expedited Disposition of Psychiatric Emergencies

Sponsor
Hebrew University of Jerusalem (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05771545
Collaborator
(none)
800
29

Study Details

Study Description

Brief Summary

The goal of this observational study is to examine the effect of using a video link for evaluation of patients in the psychiatric emergency room. Under current Israeli law, the attending physician must come in to physically examine the patient before they can be admitted involuntarily. Patients often de-compensate and even may become violent while waiting for the attending to arrive. Previous studies have shown that evaluation of such patients via video-link has an extremely high concordance with in person evaluation. This study will compare patients who are evaluated via video-link with historical controls evaluated under usual conditions. This is an observational study, which is taking advantage of a change in practice to collect data on two different ways of delivering care, via chart reviews. If successful, this study will show that the video-link is feasible and acceptable to patients and staff. The following hypotheses will be tested:

  1. The intervention will result in shorter ED time compared to historical controls.

  2. The intervention will result in fewer violent incidents compared to historical controls.

  3. The intervention will result in shorter overall hospital length of stay compared to historical controls.

Condition or Disease Intervention/Treatment Phase
  • Other: Telepsychiatry

Study Design

Study Type:
Observational
Anticipated Enrollment :
800 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Telepsychiatry to Enable Expedited Disposition of Psychiatric Emergencies
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Sep 30, 2024
Anticipated Study Completion Date :
Sep 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Pre-Innovation (Usual Care)

Patients evaluated in the psychiatric emergency department for possible involuntary admission during the year prior to the innovation in care. During this period, the attending psychiatrist was required to physically come to the hospital to examine the patient.

Innovation (Tele-Psychiatry)

Patients evaluated in the psychiatric emergency department for possible involuntary admission during the innovation period. Instead of physically coming to the hospital, the attending physician will evaluate the patient via video-link, which will be facilitated by the on-site psychiatric resident.

Other: Telepsychiatry
Instead of coming to the hospital physically, the attending psychiatrist will evaluate the patient via a video-link.

Outcome Measures

Primary Outcome Measures

  1. ED Time [Patients arrive in the ED at a specific time and leave the ED at a specific time. We will compute the amount of time spent in the ED by each patient, up to two weeks.]

    Amount of time, in hours and minutes, that the patient spends in the ED prior to disposition

Secondary Outcome Measures

  1. Violent Incidents [Patients arrive in the ED at a specific time. Those who are admitted are eventually discharged. Violent incidents can occur during the entire time spent in the hospital, whether in the ED or on the ward, up to 90 days total.]

    Adjudicated violent incidents that occur, whether in the ED or on the psychiatry ward. Includes hitting, kicking, throwing, and property destruction

  2. Hospital Length of Stay [For patients admitted to the hospital through the ED, the beginning time is their arrival to ED, the end is the time of hospital discharge, up to 90 days later.]

    Length of stay, in days, starting with time of arrival to ED

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Must be evaluated in the psychiatric ED for potential involuntary admission
Exclusion Criteria:
  • Not justice-involved (i.e., brought in by police after committing a crime)

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Hebrew University of Jerusalem

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Adam Rose, Associate Professor, Hebrew University of Jerusalem
ClinicalTrials.gov Identifier:
NCT05771545
Other Study ID Numbers:
  • HebrewUJ123
First Posted:
Mar 16, 2023
Last Update Posted:
Mar 16, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Adam Rose, Associate Professor, Hebrew University of Jerusalem
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 16, 2023